152 related articles for article (PubMed ID: 21055937)
1. Blockade of TNF in vivo using cV1q antibody reduces contractile dysfunction of skeletal muscle in response to eccentric exercise in dystrophic mdx and normal mice.
Piers AT; Lavin T; Radley-Crabb HG; Bakker AJ; Grounds MD; Pinniger GJ
Neuromuscul Disord; 2011 Feb; 21(2):132-41. PubMed ID: 21055937
[TBL] [Abstract][Full Text] [Related]
2. Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment.
Radley HG; Davies MJ; Grounds MD
Neuromuscul Disord; 2008 Mar; 18(3):227-38. PubMed ID: 18207402
[TBL] [Abstract][Full Text] [Related]
3. Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice.
Hodgetts S; Radley H; Davies M; Grounds MD
Neuromuscul Disord; 2006 Oct; 16(9-10):591-602. PubMed ID: 16935507
[TBL] [Abstract][Full Text] [Related]
4. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
[TBL] [Abstract][Full Text] [Related]
5. A single 30 min treadmill exercise session is suitable for 'proof-of concept studies' in adult mdx mice: a comparison of the early consequences of two different treadmill protocols.
Radley-Crabb H; Terrill J; Shavlakadze T; Tonkin J; Arthur P; Grounds M
Neuromuscul Disord; 2012 Feb; 22(2):170-82. PubMed ID: 21835619
[TBL] [Abstract][Full Text] [Related]
6. Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis.
Grounds MD; Torrisi J
FASEB J; 2004 Apr; 18(6):676-82. PubMed ID: 15054089
[TBL] [Abstract][Full Text] [Related]
7. Poloxamer 188 failed to prevent exercise-induced membrane breakdown in mdx skeletal muscle fibers.
Quinlan JG; Wong BL; Niemeier RT; McCullough AS; Levin L; Emanuele M
Neuromuscul Disord; 2006 Dec; 16(12):855-64. PubMed ID: 17118658
[TBL] [Abstract][Full Text] [Related]
8. Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.
De Luca A; Pierno S; Liantonio A; Cetrone M; Camerino C; Fraysse B; Mirabella M; Servidei S; Rüegg UT; Conte Camerino D
J Pharmacol Exp Ther; 2003 Jan; 304(1):453-63. PubMed ID: 12490622
[TBL] [Abstract][Full Text] [Related]
9. Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice.
Radley HG; Grounds MD
Neurobiol Dis; 2006 Aug; 23(2):387-97. PubMed ID: 16798005
[TBL] [Abstract][Full Text] [Related]
10. Streptomycin reduces stretch-induced membrane permeability in muscles from mdx mice.
Whitehead NP; Streamer M; Lusambili LI; Sachs F; Allen DG
Neuromuscul Disord; 2006 Dec; 16(12):845-54. PubMed ID: 17005404
[TBL] [Abstract][Full Text] [Related]
11. Ventilatory dysfunction in mdx mice: impact of tumor necrosis factor-alpha deletion.
Gosselin LE; Barkley JE; Spencer MJ; McCormick KM; Farkas GA
Muscle Nerve; 2003 Sep; 28(3):336-43. PubMed ID: 12929194
[TBL] [Abstract][Full Text] [Related]
12. The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice.
Messina S; Bitto A; Aguennouz M; Vita GL; Polito F; Irrera N; Altavilla D; Marini H; Migliorato A; Squadrito F; Vita G
Neuromuscul Disord; 2011 Aug; 21(8):579-89. PubMed ID: 21658942
[TBL] [Abstract][Full Text] [Related]
13. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
Schertzer JD; Ryall JG; Lynch GS
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
[TBL] [Abstract][Full Text] [Related]
14. N-Acetylcysteine treatment of dystrophic mdx mice results in protein thiol modifications and inhibition of exercise induced myofibre necrosis.
Terrill JR; Radley-Crabb HG; Grounds MD; Arthur PG
Neuromuscul Disord; 2012 May; 22(5):427-34. PubMed ID: 22206641
[TBL] [Abstract][Full Text] [Related]
15. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice.
Messina S; Bitto A; Aguennouz M; Minutoli L; Monici MC; Altavilla D; Squadrito F; Vita G
Exp Neurol; 2006 Mar; 198(1):234-41. PubMed ID: 16410003
[TBL] [Abstract][Full Text] [Related]
16. Targeted expression of insulin-like growth factor-I reduces early myofiber necrosis in dystrophic mdx mice.
Shavlakadze T; White J; Hoh JF; Rosenthal N; Grounds MD
Mol Ther; 2004 Nov; 10(5):829-43. PubMed ID: 15509501
[TBL] [Abstract][Full Text] [Related]
17. The physiological effects of IGF-1 (class 1:Ea transgene) over-expression on exercise-induced damage and adaptation in dystrophic muscles of mdx mice.
Ridgley JA; Pinniger GJ; Hamer PW; Grounds MD
Pflugers Arch; 2009 Mar; 457(5):1121-32. PubMed ID: 18726613
[TBL] [Abstract][Full Text] [Related]
18. Implications of cross-talk between tumour necrosis factor and insulin-like growth factor-1 signalling in skeletal muscle.
Grounds MD; Radley HG; Gebski BL; Bogoyevitch MA; Shavlakadze T
Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):846-51. PubMed ID: 18215180
[TBL] [Abstract][Full Text] [Related]
19. Weekly oral prednisolone improves survival and strength in male mdx mice.
Keeling RM; Golumbek PT; Streif EM; Connolly AM
Muscle Nerve; 2007 Jan; 35(1):43-8. PubMed ID: 16969833
[TBL] [Abstract][Full Text] [Related]
20. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
